These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34795301)

  • 1. Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination.
    Wild K; Smits M; Killmer S; Strohmeier S; Neumann-Haefelin C; Bengsch B; Krammer F; Schwemmle M; Hofmann M; Thimme R; Zoldan K; Boettler T
    Nat Commun; 2021 Nov; 12(1):6720. PubMed ID: 34795301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.
    Spensieri F; Siena E; Borgogni E; Zedda L; Cantisani R; Chiappini N; Schiavetti F; Rosa D; Castellino F; Montomoli E; Bodinham CL; Lewis DJ; Medini D; Bertholet S; Del Giudice G
    PLoS One; 2016; 11(6):e0157066. PubMed ID: 27336786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC
    PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ
    Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.
    Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM
    Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.
    Pallikkuth S; de Armas LR; Rinaldi S; George VK; Pan L; Arheart KL; Pahwa R; Pahwa S
    PLoS Biol; 2019 May; 17(5):e3000257. PubMed ID: 31100059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection.
    Amoah S; Mishina M; Praphasiri P; Cao W; Kim JH; Liepkalns JS; Guo Z; Carney PJ; Chang JC; Fernandez S; Garg S; Beacham L; Holtz TH; Curlin ME; Dawood F; Olsen SJ; Gangappa S; Stevens J; Sambhara S
    J Infect Dis; 2019 Jul; 220(5):743-751. PubMed ID: 31045222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli G; Groth N; Del Giudice G
    Hum Vaccin Immunother; 2012 Feb; 8(2):216-27. PubMed ID: 22426371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
    Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
    Transpl Infect Dis; 2015 Jun; 17(3):371-9. PubMed ID: 25817044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin.
    Park BR; Kim KH; Kotomina T; Kim MC; Kwon YM; Jeeva S; Jung YJ; Bhatnagar N; Isakova-Sivak I; Mezhenskaya D; Rudenko L; Wang BZ; Kang SM
    Sci Rep; 2021 Feb; 11(1):4151. PubMed ID: 33603072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humans.
    Kang KS; Lee N; Shin MS; Kim SD; Yu Y; Mohanty S; Belshe RB; Montgomery RR; Shaw AC; Kang I
    Clin Immunol; 2013 May; 147(2):79-88. PubMed ID: 23578549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination.
    Dauner A; Agrawal P; Salvatico J; Tapia T; Dhir V; Shaik SF; Drake DR; Byers AM
    Vaccine; 2017 Oct; 35(41):5487-5494. PubMed ID: 28413134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
    Houser KV; Pearce MB; Katz JM; Tumpey TM
    J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
    Cole ME; Kundu R; Abdulla AF; Andrews N; Hoschler K; Southern J; Jackson D; Miller E; Zambon M; Turner PJ; Tregoning JS
    Clin Exp Immunol; 2021 Apr; 204(1):125-133. PubMed ID: 33314126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.